CORRELATION OF TMPRSS2-ERG GENE FUSION STATUS WITH CLINICOPATHOLOGICAL CHARACTERISTICS IN PROSTATE CANCER OF IRAQI PATIENTS

Authors

  • Ammar K. A.
  • M. F. Altaee

DOI:

https://doi.org/10.36103/ijas.v53i3.1556

Keywords:

“FISH” technique, age, gender, formalin-fixed tissues

Abstract

The aim of this study was to establish the existence and interaction of TMPRSS2 – ERG gene fusion status with clinicopathological features of prostate cancer patients. This research consisted of 123 embedded formalin-fixed tissues obtained from the prostate tumor patients. The above gene fusion is detected through the technique of fluorescent in situ hybridization (FISH) by means of a triple color probe. Seven samples have not been scored due to technical difficulties and 46 patients have fusion (39.6%), while the remaining (70) have not been seen with fusion. Of the 46 fusion-positive, 17 (36%) were caused by ERG-translocation, of the other 29 (63%) were caused by the interstitial segment deletion between the two genes due to their sequential position. In order to find a substantial correlation between 116 patients (fusion took place in 46 and non-fusion in 70) with clinicopathological features, the following findings were calculated: Our findings recorded non-significant correlation at age, BMI and tumor size at which (P-value >0.05).While results showed significant association with: pathological T stage (P value = 0.011), Gleason score (P value = 0.002), perineural invasion (P value = 0.047) and PSA (P value = 0.033). The clinicopathological features which had a considerable correlation with fusion status are very important as they aid the doctors in prognosis and treatment of such tumor.

References

Attard, G., J. Clark, L. Ambroisine, G. Fisher, G. Kovacs, P. Flohr and C. Cooper. 2008. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene. 27(3): 253-263

Bhanushali, A., P. Rao, V. Raman, P. Kokate, A. Ambekar, S. Mandva, S. Bhatia, and B.R Das. 2018. Status of TMPRSS2–ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val Polymorphism.Prostate International. 6(4): 145-150

Brown, L.A. and D. Huntsman, 2007. Fluorescent in situ hybridization on tissue microarrays: challenges and solutions. Journal of Molecular Histology. 38(2): 151-157

Büscheck, F., M. Sulimankhil, N Melling, D. Höflmayer, C. Hube‐Magg, R. Simon, and C. Fraune. 2020. Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients. Cancer Medicine. 9(4): 1409-1418

Čamdžić, N., S. Kuskunović-Vlahovljak, M. Dorić, S. Radović, E.L Salčin, and M. Babić. 2020. Serum total prostate-specific antigen (tPSA): correlation with diagnosis and grading of prostate cancer in core needle biopsy. Medicinski Glasnik: Official Publication of the Medical Association of Zenica-doboj Canton, Bosnia and Herzegovina. 18(1).

Chan, J. K. 2014. The wonderful colors of the hematoxylin–eosin stain in diagnostic surgical pathology. International Journal of Surgical Pathology. 22(1): 12-32

Demichelis, F., K. Fall, S. Perner, O. Andrén, F. Schmidt, S. R Setlur and M. A. Rubin. 2007. TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene. 26(31): 4596-4599

Eguchi, F. C., E. F. Faria, C. S. Neto, A. Longatto-Filho, C. Zanardo-Oliveira, S. R. Taboga, and S. G. Campos. 2014. The role of TMPRSS2: ERG in molecular stratification of PCa and its association with tumor aggressiveness: a study in Brazilian Patients. Scientific Reports. 4(1): 1-6

Esgueva, R., S. Perner, C. J. LaFargue, V. Scheble, C. Stephan, M. Lein, and M. A. Rubin. 2010. Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort. Modern Pathology. 23(4): 539-546

Goddard, J. C., 2019. The history of the prostate, part one: say what you see. Trends in Urology & Men's Health. 10(1): 28-30

Gopalan, A., M. A. Leversha, J. M. Satagopan, Q. Zhou, H. A. Al-Ahmadie, S. W. Fine, J. A. Eastham, P. T. Scardino, H. I. Scher, S. K. Tickoo, and V. E. Reuter. 2009. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Research. 69(4): 1400-1406

Hagen, R. M., P. Adamo, S. Karamat, J. Oxley, J. J. Aning, D. Gillatt, and A. Rhodes. 2014. Quantitative analysis of ERG expression and its splice isoforms in formalin-fixed, paraffin-embedded prostate cancer samples: association with seminal vesicle invasion and biochemical recurrence. American Journal of Clinical Pathology. 142(4): 533-540

Kolar, Z., A. Burdova, T. Jamaspishvili, J. Bouchal, R. Kucerova, M. Bienova, M. Kral, and V. Student. 2014. Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2β expression to TMPRSS2-ERG fusion status in prostate cancer. Neoplasma, 61(1): 9-16

Lee, S.R., Y. D. Choi, and N. H. Cho. 2018. Association between pathologic factors and ERG expression in prostate cancer: Finding pivotal networking. Journal of Cancer Research and Clinical Oncology. 144(9): 1665-1683

Maha Fakhry Altaee, R. W. Younis and K. Zaid Kamona 2020. Activity of Annona Squamosa peels extracts against two pathogenic bacteria and two blood cancer cell lines. Iraqi Journal of Science. 51(6): 1496-1503

Mosquera, J. M., R. Mehra, M. M. Regan, S. Perner, E. M. Genega, G. Bueti, R. B. Shah, S. Gaston, S. A. Tomlins, J. T. Wei, and M. C. Kearney. 2009. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clinical Cancer Research. 15(14): 4706-4711

Mucci, L.; N. Luedeke; A. Rinckleb, S. Kolb; J. L. Wright; C. Maier; M. L. Neuhouser and J. L. Stanford 2008. Obesity and the TMPRSS2: ERG translocation in prostate cancer. AACR. Am. J. Epidemiol.181(9): 706–713

Park, K., S. A. Tomlins, K. M. Mudaliar, Y. L. Chiu, R. Esgueva, R. Mehra, K. Suleman, S. Varambally, J. C. Brenner, T. MacDonald and A. Srivastava. 2010. Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia. 12(7): 590-IN21

Perner, S., F. Demichelis, R. Beroukhim, F. H. Schmidt, J. M. Mosquera, S. Setlur and M. A. Rubin. 2006 TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Research. 66(17): 8337-8341

Schoenborn, J. R., P. Nelson and M. Fang. 2013. Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification. Clinical Cancer Research, 19(15): 4058-4066

Sung, J.Y., H. G. Jeon, B. C. Jeong, S. I. Seo, S. S. Jeon, H. M. Lee, H. Y. Choi, S. Y. Kang, Y. L. Choi and G. Y. Kwon. 2016. Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion. Journal of Clinical Pathology. 69(7): 586-592

Shkaaer, M. T. and N. M. Utba. 2019. IL-18 Gene Polymorphisms Impacts on Its Serum Levels in Prostate Cancer Iraqi Patients. Iraqi Journal of Science. 60(6): 1188-1196

Suh, J. H., J. H. Park, C. Lee and K. C. Moon. 2017. Intrafocal heterogeneity of ERG protein expression and gene fusion pattern in prostate cancer. The Prostate. 77(14): 1438-1445

Suryavanshi, M., A. Mehta, J. Jaipuria, A. K. Sharma, S. Rawal and N. Seth. 2015. Weaker ERG expression in patients with ERG-positive prostate cancer is associated with advanced disease and weaker androgen receptor expression: An Indian outlook. in Urologic Oncology: Seminars and Original Investigations. 33(7): 331-e9

Tomlins, S. A., A. Bjartell, A. M. Chinnaiyan, G. Jenster, R. K. Nam, M. A. Rubin and J. A. Schalken. 2009. ETS gene fusions in prostate cancer: from discovery to daily clinical practice. European Urology. 56(2): 275-286

Vanaja, D. K., J. C. Cheville, S. J. Iturria and C. Y. Young. 2003. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Research. 63(14): 3877-3882

Yoshimoto, M., A. M. Joshua, I. W. Cunha, R. A. Coudry, F. P. Fonseca, O. Ludkovski and J. A. Squire. 2008. Absence of TMPRSS2: ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Modern Pathology. 21(12): 1451-1460

Young, B., P. Woodford and G. O'Dow. 2013. Wheater's Functional Histology E-Book: A Text and Colour Atlas. Elsevier Health Sciences.

Downloads

Published

2022-06-29

Issue

Section

Articles

How to Cite

A., A. K. ., & Altaee, M. F. . (2022). CORRELATION OF TMPRSS2-ERG GENE FUSION STATUS WITH CLINICOPATHOLOGICAL CHARACTERISTICS IN PROSTATE CANCER OF IRAQI PATIENTS. IRAQI JOURNAL OF AGRICULTURAL SCIENCES, 53(3), 487-495. https://doi.org/10.36103/ijas.v53i3.1556

Similar Articles

61-70 of 386

You may also start an advanced similarity search for this article.